Ads
related to: baird- Fees & Commissions
See Our Trading Fees & Commissions.
No Trade Or Account Minimums.
- Compare For Yourself
See How Schwab Compares In Pricing,
Service, And Trading Education.
- Fees & Commissions
Search results
Baird raises Cencora share price target citing five-year forecasts By Investing.com
Investing.com· 1 day agoOn Wednesday, Baird, a global financial services firm, adjusted its share price target for Cencora...
Salesforce stock target cut, Baird maintains Outperform By Investing.com
Investing.com· 3 hours agoOn Thursday, Baird adjusted its price target on shares of Salesforce.com (NYSE:CRM) to $295 from the...
HEICO stock upgraded by Baird on strong 2Q24 results By Investing.com
Investing.com· 9 hours agoThursday saw Baird maintain an Outperform rating on HEICO Corporation (NYSE:HEI) stock, with an...
Baird cuts nCino stock target, maintains neutral By Investing.com
Investing.com· 3 hours agoOn Thursday, Baird adjusted its stance on nCino Inc. (NASDAQ:NCNO), a cloud banking software...
Agilent shares face pressure with lower price target, Outperform intact By Investing.com
Investing.com· 3 hours agoThursday, Baird adjusted its outlook on Agilent Technologies Inc. (NYSE:A), a provider of...
Kevin Costner's Ex-wife Allegedly Planning To Marry The Actor's Former Financier Friend
TheBlast via Yahoo News· 1 day agoSuch a good moment, not just for me, but for the actors who came with me, for people who believed in...
Baird downgrades WESCO stock, cites concerns over revenue growth By Investing.com
Investing.com· 1 day agoOn Wednesday, WESCO International (NYSE:WCC) experienced a shift in its stock outlook as Baird...
Nvidia Holds Near Record Highs As Stock Split Looms; Is Nvidia A Buy Now?
Investor's Business Daily· 3 hours agoNvidia inched up to a new high on Thursday before pulling back. Nvidia's market cap is approaching...
Baird predicts steady growth for SAGE Therapeutics at $15 target By Investing.com
Investing.com· 24 hours agoBaird Equity Research has initiated coverage of SAGE Therapeutics Inc (NASDAQ:SAGE), assigning it a...
Baird initiates Sage Therapeutics stock with $15 PT following Zurzuvae launch By Investing.com
Investing.com· 1 day agoBaird has initiated coverage on Sage Therapeutics (NASDAQ:SAGE) with a Neutral rating and a price...